In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biomarkers for Psychiatric Drugs: Outlier or Opportunity?

Executive Summary

A handful of companies are pursuing predictive genetic tests for evaluating psychiatric drugs. The need is apparent, and an early success could trigger a rapid shift in thinking about the sustainability of building a business around biomarkers in a therapeutic area sometimes considered the least likely to benefit near term from their development. That said, firms in this area--and elsewhere--must be wary of leaning too heavily on pharma companies as supportive partners.
Advertisement

Related Content

Will COX-2 + Biomarker = Success? Novartis Tests the Frontiers of Companion Diagnostics
Clinical Data Psyched For Vilazodone NDA Filing In Second Half
What New Her2 Tests Say about Personalized Medicine
What New Her2 Tests Say about Personalized Medicine
The Unsung Vytorin Victim: Primary-Care Marketing
The Unsung Vytorin Victim: Primary-Care Marketing
Biomarker Diagnostics: Place Your Bets Wisely
Biomarker Diagnostics: Place Your Bets Wisely
Genomics and Proteomics Forays into Psychiatric Illness
The New Diagnostics Companies

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel